Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-01-19 @ 7:29 PM
Study NCT ID:
NCT00637559
Status:
COMPLETED
Last Update Posted:
2011-01-25
First Post:
2008-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Barrett's Esophagus - 315 - 3 Way Cross-Over
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
315
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Tore Lind, MD - Nexium Medical Science Director
Old Organization:
Astra Zeneca